37 /100
MEDIUM RISK
Score updated May 30, 2026

GALT — Galectin Therapeutics Inc. Dilution Risk Tracker

Track GALT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GALT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
65
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
26%
📉 Score Deterioration 40%
• Score rose 16 points recently (worsening)
💰 Capital Raise 15%
• Under 12 months cash (9mo)
🔄 Reverse Split 10%
• 9 months cash with weak price
🔔 Track GALT — Get forecast alerts →

💹 Market Data

Market Cap$165.96M
Shares Outstanding65.86M
Float47.19M
Cash$14.11M
Debt$138.70M
Short InterestN/A

🏛 Institutional Holdings

1 institutional holders · 12.4K shares
#1 49 WEALTH MANAGEMENT, LLC 12.4K shares

📉 Short Interest

Short Interest7.36M
Days to Cover21.3
% of Float15.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Apr 16, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track GALT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GALT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GALT
📊 GALT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GALT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.